Navigation überspringen
Universitätsbibliothek Heidelberg
Status: Bibliographieeintrag

Verfügbarkeit
Standort: ---
Exemplare: ---
heiBIB
 Online-Ressource
Verfasst von:Kröger, Knut [VerfasserIn]   i
 Schwertfeger, M. [VerfasserIn]   i
 Pittrow, D. [VerfasserIn]   i
 Diehm, Curt [VerfasserIn]   i
Titel:Management of patients with peripheral arterial disease in primary care
Titelzusatz:a cross-sectional study in Germany
Verf.angabe:K. Kröger, M. Schwertfeger, D. Pittrow, C. Diehm
E-Jahr:2010
Jahr:17 May 2010
Umfang:10 S.
Fussnoten:Gesehen am 06.03.2023
Titel Quelle:Enthalten in: The international journal of clinical practice
Ort Quelle:London : Hindawi Limited, 2004
Jahr Quelle:2010
Band/Heft Quelle:64(2010), 7, Seite 875-884
ISSN Quelle:1742-1241
Abstract:Background: Studies in the primary care setting are of high interest for assessing the management situation of patients with manifestations of atherothrombosis. Aims: Therefore, we documented diagnostic procedures, characteristics, and management of patients with symptomatic and asymptomatic peripheral arterial disease (PAD). Materials & Methods: Prospective cross-sectional study in primary care practices throughout Germany. Results: A total of 671 patients with newly diagnosed PAD were included (mean age 69.1 years; 62.1% men). Cardiovascular risk factors were highly prevalent in the total PAD group: arterial hypertension in 84.2%, hyperlipidaemia in 75.5%, present smoking in 45.0% and diabetes mellitus in 47.3%. Atherothrombotic comorbidities were also frequent: coronary artery disease in 44.9% and cerebrovascular disease in 28.1%. For confirmation of diagnosis, patients were referred to specialists in 66.9% of cases. Overall, ankle brachial index was measured in 89.0%, and a clinical PAD score assessed in 66.6% (agreement of both measures with Cohen’s kappa only, κ = 0.039; p = 0.209). Drug treatment of risk factors (as secondary prophylaxis) in line with current guidelines was reported in a high percentage of patients: 88.6% with any antiplatelet drug, 69.3% with statins, 62.4% with angiotensin converting enzyme inhibitors, 23.5% with AT1 receptor blockers and 43.9% with beta-blockers. Between asymptomatic and symptomatic PAD, differences in the risk factor/comorbidity profiles were small; however, the latter group received intensified treatment. Conclusion: Our findings confirm that patients with PAD pose a substantial challenge to physicians because of their high number of comorbidities. Compared with previous studies, management of such patients appears to have improved.
DOI:doi:10.1111/j.1742-1241.2010.02337.x
URL:Bitte beachten Sie: Dies ist ein Bibliographieeintrag. Ein Volltextzugriff für Mitglieder der Universität besteht hier nur, falls für die entsprechende Zeitschrift/den entsprechenden Sammelband ein Abonnement besteht oder es sich um einen OpenAccess-Titel handelt.

Volltext: https://doi.org/10.1111/j.1742-1241.2010.02337.x
 Volltext: https://onlinelibrary.wiley.com/doi/abs/10.1111/j.1742-1241.2010.02337.x
 DOI: https://doi.org/10.1111/j.1742-1241.2010.02337.x
Datenträger:Online-Ressource
Sprache:eng
K10plus-PPN:1838178147
Verknüpfungen:→ Zeitschrift

Permanenter Link auf diesen Titel (bookmarkfähig):  https://katalog.ub.uni-heidelberg.de/titel/69047940   QR-Code
zum Seitenanfang